Literature DB >> 26115221

Novel mechanism of transcriptional regulation of cell matrix protein through CREB.

Samy L Habib1, Sumathy Mohan, Sitai Liang, Baojie Li, Mukesh Yadav.   

Abstract

The transcription mechanism(s) of renal cell matrix accumulation in diabetes does not explored. Phosphorylation of the transcription factor cAMP-responsive element binding protein (CREB) significantly increased in cells treated with high glucose (HG) compared to cell grown in normal glucose (NG). Cells pretreated with rapamycin before exposure to HG showed significant decrease phosphorylation of CREB, increase in AMPK activity and decrease protein/mRNA and promoter activity of fibronectin. In addition, cells transfected with siRNA against CREB showed significant increase in AMPK activity, decrease in protein/mRNA and promoter activity of fibronectin. Cells treated with HG showed nuclear localization of p-CREB while pretreated cells with rapamycin reversed HG effect. Moreover, gel shift analysis shows increase binding of CREB to fibronectin promoter in cells treated with HG while cells pretreated with rapamycin reversed the effect of HG. Furthermore, db/db mice treated with rapamycin showed significant increase in AMPK activity, decrease in expression of p-CREB and protein/mRNA of fibronectin. Strong staining of fibronectin and p-CREB was detected in kidney cortex of db/db mice while treated mice with rapamycin reversed hyperglycemia effect. In summary, our data provide a novel mechanism of transcriptional regulation of fibronectin through CREB that may be used as therapeutic approach to prevent diabetes complications.

Entities:  

Keywords:  AMPK; CREB; cell matrix; fibronectin; renal cells; transcription

Mesh:

Substances:

Year:  2015        PMID: 26115221      PMCID: PMC4613654          DOI: 10.1080/15384101.2015.1064204

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

Review 1.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

2.  Alterations in tubular epithelial cells in diabetic nephropathy.

Authors:  Samy L Habib
Journal:  J Nephrol       Date:  2013-08-06       Impact factor: 3.902

Review 3.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

Authors:  R E Gilbert; M E Cooper
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

4.  Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathway.

Authors:  Eric S White; Rommel L Sagana; Adam J Booth; Mei Yan; Ashley M Cornett; Christopher A Bloomheart; Jessica L Tsui; Carol A Wilke; Bethany B Moore; Jeffrey D Ritzenthaler; Jesse Roman; Andrés F Muro
Journal:  Exp Cell Res       Date:  2010-07-13       Impact factor: 3.905

5.  Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells.

Authors:  Samy L Habib; Besant K Bhandari; Nahed Sadek; Sherry L Abboud-Werner; Hanna E Abboud
Journal:  Carcinogenesis       Date:  2010-09-13       Impact factor: 4.944

6.  Tuberin inhibits production of the matrix protein fibronectin in diabetes.

Authors:  Samy L Habib; Mukesh Yadav; Shaza Tizani; Basant Bhandari; Anthony J Valente
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

7.  Transcriptional regulation of gene expression during osmotic stress responses by the mammalian target of rapamycin.

Authors:  M Carmen Ortells; Beatriz Morancho; Katherine Drews-Elger; Benoit Viollet; Keith R Laderoute; Cristina López-Rodríguez; Jose Aramburu
Journal:  Nucleic Acids Res       Date:  2012-01-28       Impact factor: 16.971

8.  Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes.

Authors:  Samy L Habib; Sitai Liang
Journal:  Oncotarget       Date:  2014-05-15

9.  Novel mechanism of regulation of fibrosis in kidney tumor with tuberous sclerosis.

Authors:  Sitai Liang; Gabriela Cuevas; Shaza Tizani; Tiffanie Salas; Huijuan Liu; Baojie Li; Samy L Habib
Journal:  Mol Cancer       Date:  2013-05-25       Impact factor: 27.401

10.  The mTOR pathway controls cell proliferation by regulating the FoxO3a transcription factor via SGK1 kinase.

Authors:  Shunsuke Mori; Shigeyuki Nada; Hironobu Kimura; Shoji Tajima; Yusuke Takahashi; Ayaka Kitamura; Chitose Oneyama; Masato Okada
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more
  4 in total

1.  Kidney atrophy vs hypertrophy in diabetes: which cells are involved?

Authors:  Samy L Habib
Journal:  Cell Cycle       Date:  2018-07-30       Impact factor: 4.534

2.  Roles of p300 and cyclic adenosine monophosphate response element binding protein in high glucose-induced hypoxia-inducible factor 1α inactivation under hypoxic conditions.

Authors:  Lingtao Ding; Minlie Yang; Tianlan Zhao; Guozhong Lv
Journal:  J Diabetes Investig       Date:  2017-01-24       Impact factor: 4.232

Review 3.  What turns CREB on? And off? And why does it matter?

Authors:  André Steven; Michael Friedrich; Paul Jank; Nadine Heimer; Jan Budczies; Carsten Denkert; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2020-04-28       Impact factor: 9.261

4.  β-LAPachone is renoprotective in streptozotocin-induced diabetic mice via regulating the PI3K/Akt/mTOR signaling pathway.

Authors:  Davoud Sanajou; Saman Bahrambeigi; Somayeh Aslani
Journal:  Iran J Basic Med Sci       Date:  2021-05       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.